SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-036592
Filing Date
2016-08-05
Accepted
2016-08-05 15:11:48
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20160630_10q.htm 10-Q 1303261
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 1894
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 11339
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 11295
5 EXHIBIT 32 ex32.htm EX-32 9474
12 a3.jpg GRAPHIC 132598
13 a2.jpg GRAPHIC 351230
14 a1.jpg GRAPHIC 235327
  Complete submission text file 0001437749-16-036592.txt   6555671

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS insy-20160630.xml EX-101.INS 1286287
7 EXHIBIT 101.SCH insy-20160630.xsd EX-101.SCH 42388
8 EXHIBIT 101.CAL insy-20160630_cal.xml EX-101.CAL 38213
9 EXHIBIT 101.DEF insy-20160630_def.xml EX-101.DEF 297144
10 EXHIBIT 101.LAB insy-20160630_lab.xml EX-101.LAB 263082
11 EXHIBIT 101.PRE insy-20160630_pre.xml EX-101.PRE 320157
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 161810748
SIC: 2834 Pharmaceutical Preparations